BioAtla Inc (BCAB)
2.54
+0.29
(+12.89%)
USD |
NASDAQ |
Apr 26, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
BioAtla Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2021 | 0.0038 |
| March 31, 2021 | 0.0035 |
| December 31, 2020 | 0.0032 |
| September 30, 2020 | -0.0092 |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.3238 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.3238
Minimum
Dec 2019
0.0038
Maximum
Jun 2021
-0.0645
Average
0.0032
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Marinus Pharmaceuticals Inc | 4.353 |
| Equillium Inc | 0.00 |
| Poseida Therapeutics Inc | 0.565 |
| Biomea Fusion Inc | -- |
| Candel Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 119.66M |
| Total Liabilities (Quarterly) | 48.99M |
| Shareholders Equity (Quarterly) | 70.67M |